Court rules against Pfizer on Norvasc patent

03/22/2007 | Washington Post, The

A generic version of Pfizer's blood pressure drug Norvasc could hit the market soon following a legal setback for the drugmaker. A federal Court of Appeals reversed a lower court ruling that supported Pfizer's patent against a challenge by Canadian generic drugmaker Apotex. Mylan Laboratories also aims to market a generic version.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID